| 0 | ℹ |
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-09 | #covid-19 #clinical trial #antiviral #nucleoside | |
| 0 | ℹ |
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-09 | #covid-19 #clinical trial #antiviral #viral rebound |